2024 Q3 Form 10-Q Financial Statement

#000009144024000051 Filed on July 18, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $1.247B $1.280B
YoY Change -2.9% 0.34%
Cost Of Revenue $587.9M $612.4M
YoY Change -4.27% 3.2%
Gross Profit $659.5M $667.5M
YoY Change -1.66% -2.15%
Gross Profit Margin 52.87% 52.15%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $24.60M $24.60M
YoY Change -0.81% 36.67%
% of Gross Profit 3.73% 3.69%
Operating Expenses $335.4M $305.8M
YoY Change 2.66% -14.13%
Operating Profit $324.1M $350.5M
YoY Change -5.76% 7.48%
Interest Expense $1.100M $400.0K
YoY Change -121.57% -96.77%
% of Operating Profit 0.34% 0.11%
Other Income/Expense, Net $20.60M $18.70M
YoY Change 121.51% 23.03%
Pretax Income $332.2M $356.9M
YoY Change -4.57% 8.51%
Income Tax $74.70M $79.30M
% Of Pretax Income 22.49% 22.22%
Net Earnings $251.1M $271.2M
YoY Change -4.89% 9.05%
Net Earnings / Revenue 20.13% 21.19%
Basic Earnings Per Share $4.77 $5.15
Diluted Earnings Per Share $4.70 $5.07
COMMON SHARES
Basic Shares Outstanding 52.68M shares 52.72M shares
Diluted Shares Outstanding 53.40M shares 53.50M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.313B $1.233B
YoY Change 50.73% 47.84%
Cash & Equivalents $1.313B $1.233B
Short-Term Investments
Other Short-Term Assets $148.4M $147.0M
YoY Change 15.04% 6.52%
Inventory $995.8M $965.0M
Prepaid Expenses
Receivables $796.4M $783.5M
Other Receivables $746.8M $729.9M
Total Short-Term Assets $4.001B $3.858B
YoY Change 13.23% 10.83%
LONG-TERM ASSETS
Property, Plant & Equipment $626.3M $613.6M
YoY Change 5.83% 6.2%
Goodwill $1.087B $1.068B
YoY Change 3.62% 1.65%
Intangibles $420.6M $414.9M
YoY Change 4.26% 1.69%
Long-Term Investments
YoY Change
Other Assets $17.10M $16.90M
YoY Change -89.44% 31.01%
Total Long-Term Assets $3.953B $3.902B
YoY Change 6.91% 7.06%
TOTAL ASSETS
Total Short-Term Assets $4.001B $3.858B
Total Long-Term Assets $3.953B $3.902B
Total Assets $7.953B $7.760B
YoY Change 10.0% 8.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $270.0M $271.1M
YoY Change -1.53% -4.24%
Accrued Expenses $592.1M $585.5M
YoY Change -0.47% -6.06%
Deferred Revenue
YoY Change
Short-Term Debt $14.30M $15.70M
YoY Change -19.66% -13.74%
Long-Term Debt Due $800.0K $1.000M
YoY Change -52.94% -47.37%
Total Short-Term Liabilities $956.4M $950.1M
YoY Change -0.61% -4.89%
LONG-TERM LIABILITIES
Long-Term Debt $1.185B $1.185B
YoY Change -0.03% 0.09%
Other Long-Term Liabilities $87.90M $86.80M
YoY Change -60.72% 2.84%
Total Long-Term Liabilities $1.273B $1.272B
YoY Change -9.66% 0.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $956.4M $950.1M
Total Long-Term Liabilities $1.273B $1.272B
Total Liabilities $2.456B $2.451B
YoY Change -0.72% -1.69%
SHAREHOLDERS EQUITY
Retained Earnings $7.439B $7.286B
YoY Change 12.11% 12.82%
Common Stock $67.50M $67.50M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.475B $5.286B
YoY Change
Total Liabilities & Shareholders Equity $7.953B $7.760B
YoY Change 10.0% 8.9%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $251.1M $271.2M
YoY Change -4.89% 9.05%
Depreciation, Depletion And Amortization $24.60M $24.60M
YoY Change -0.81% 36.67%
Cash From Operating Activities $274.2M $301.1M
YoY Change 1.44% -0.17%
INVESTING ACTIVITIES
Capital Expenditures $20.40M $23.20M
YoY Change -20.93% 0.87%
Acquisitions
YoY Change
Other Investing Activities -$20.10M -$37.00M
YoY Change -70.78% -4725.0%
Cash From Investing Activities -$40.50M -$60.20M
YoY Change -57.19% -17.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -156.2M -127.9M
YoY Change 14.43% -15.91%
NET CHANGE
Cash From Operating Activities 274.2M 301.1M
Cash From Investing Activities -40.50M -60.20M
Cash From Financing Activities -156.2M -127.9M
Net Change In Cash 77.50M 113.0M
YoY Change 97.7% 47.52%
FREE CASH FLOW
Cash From Operating Activities $274.2M $301.1M
Capital Expenditures $20.40M $23.20M
Free Cash Flow $253.8M $277.9M
YoY Change 3.8% -0.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
350500000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
343900000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
689700000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
670000000.0 usd
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
800000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1000000.0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
900000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1000000.0 shares
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
51700000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
84600000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1916000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
177.79
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
233000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
269.01
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
206000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
170.74
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
26000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
243.37
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1917000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
188.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y6M
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
141000000.0 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1464000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
169.08
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y4M24D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
135100000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
55.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
51.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
22700000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
24500000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
47100000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
9500000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
9100000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52661542 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
834342 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53495884 shares
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
14900000 usd
CY2024Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3600000 usd
CY2024Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3300000 usd
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
15200000 usd
CY2024Q2 us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
11200000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
350500000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
343900000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
689700000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
670000000.0 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0000091440-24-000051-index-headers.html Edgar Link pending
0000091440-24-000051-index.html Edgar Link pending
0000091440-24-000051.txt Edgar Link pending
0000091440-24-000051-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q2fy24_ex311.htm Edgar Link pending
q2fy24_ex312.htm Edgar Link pending
q2fy24_ex321.htm Edgar Link pending
q2fy24_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sna-20240629.htm Edgar Link pending
sna-20240629.xsd Edgar Link pending
sna-20240629_cal.xml Edgar Link unprocessable
sna-20240629_def.xml Edgar Link unprocessable
sna-20240629_lab.xml Edgar Link unprocessable
sna-20240629_pre.xml Edgar Link unprocessable
sna-20240629_htm.xml Edgar Link completed